Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00722098 · ClinicalTrials.gov registry record · Phase 2
Comparison Study of Dendritic Cell Vaccine With and Without Cyclophosphamide to Treat Stage IV Melanoma Patients
A Phase 2 study, sponsored by Baylor Research Institute.
- Terminated
- Registry status
- Phase 2
- Development phase
- 9
- Enrollment target
NCT00722098: Clinical Trial Phase 2 study, sponsored by Baylor Research Institute.
NCT00722098 is a Phase 2 study that was terminated before completion, run by Baylor Research Institute. The registered enrollment target is 9 participants, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (93% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00722098, a Phase 2 study, was terminated before completion, sponsored by Baylor Research Institute.
- TERMINATED
- Registry status
- Phase 2
- Development phase
- 9 participants
- Enrollment target
Study Summary
The purpose of this study is to determine whether the combination of chemotherapy (Cyclophosphamide) and CD34-DC vaccines results in the improved rate of clinical responses for stage IV melanoma patients.
Interventions
- BIOLOGICAL DC Vaccine & Cyclophosphamide
- BIOLOGICAL DC Vaccine & Placebo
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 9 participants |
| Start Date | 2008-06 |
| Est. Completion | 2012-07 |
| Phase | Phase 2 |
Why NCT00722098 stopped before completion
NCT00722098 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 9 participants, a relatively small participant target, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (93% lower).
The record links to 0 conditions, and to 2 interventions - of which DC Vaccine & Cyclophosphamide is the first listed.
NCT00722098 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00722098 about?
NCT00722098 is a clinical study titled "Comparison Study of Dendritic Cell Vaccine With and Without Cyclophosphamide to Treat Stage IV Melanoma Patients". The purpose of this study is to determine whether the combination of chemotherapy (Cyclophosphamide) and CD34-DC vaccines results in the improved rate of clinical responses for stage IV melanoma patients.
What is the current status of trial NCT00722098?
This trial is currently terminated. It is a Phase 2 study. The enrollment target is 9 participants. The study started on 2008-06. Estimated completion is 2012-07.
What interventions are being tested in trial NCT00722098?
The interventions under investigation include: DC Vaccine & Cyclophosphamide (BIOLOGICAL), DC Vaccine & Placebo (BIOLOGICAL).
Who is sponsoring clinical trial NCT00722098?
This trial is sponsored by Baylor Research Institute, which has 180 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00722098's enrollment target sits among peer trials
9 1989th of 2000 higher than 11 of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia